Please login to the form below

Not currently logged in
Email:
Password:

Truberzi

This page shows the latest Truberzi news and features for those working in and with pharma, biotech and healthcare.

NICE backs Allergan's IBS therapy Truberzi

NICE backs Allergan's IBS therapy Truberzi

For doctors to now be able to prescribe Truberzi, a targeted treatment, this will signify real change for IBS-D sufferers," he added. ... It has also said Truberzi should only be offered in secondary care and must be discontinued after four weeks if the

Latest news

  • HIV prevention pill heads July CHMP recommendations HIV prevention pill heads July CHMP recommendations

    Other positive recommendations were given for Aptalis' Truberzi (eluxadoline) as a treatment for irritable bowel syndrome with diarrhoea, along with two biosimilar versions of Sanofi's clot-busting drug Lovenox (enoxaparin) -

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics